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Cyclins: Growing pains for Drosophila
Edan Foley and Frank Sprenger
Tradition holds that cyclin D is required for the initiation
of cell division; recent studies in Drosophila, however,
suggest that cyclin D has a separate function in
governing growth.
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Events such as development, patterning and cancer
progression are necessarily tied in to cell division. It is
thus no surprise that the initial step in cell division is
tightly regulated. Our current understanding of this process
is that a cyclin-dependent kinase, either Cdk4 or Cdk6,
partnered with its regulatory subunit cyclin D, responds to
mitogenic signals by phosphorylating ‘pocket’ proteins,
such as the retinoblastoma protein (Rb). Phosphorylation
of Rb leads to release of the transcription factor E2F,
which is then free to activate the transcription of several
genes involved in DNA replication [1]. Indeed, mutations
in the genes encoding cyclin D, Rb and the cyclin D
inhibitor p16 are observed in many human cancers [2].
The fruitfly Drosophila presents an ideal organism for
investigating the function of cyclin D. The recently
completed sequence of the Drosophila genome has revealed
that the fruitfly has only one cycD gene and only one gene
encoding a cyclin D kinase partner, Cdk4/6. For simplicity,
we shall refer to Cdk4/6 as Cdk4. Two groups [3,4] have
recently investigated the consequences of mutations in
Cdk4 or overexpression of the genes for Cdk4 and
cyclin D in Drosophila, and have come up with some sur-
prising findings. Cyclin D does not appear to be essential
for cell-cycle progression; rather, it promotes growth.
Moreover, cyclin D-dependent regulation of growth is at
least partly independent of Rb.
An impressive amount of data has accumulated in the last
decade in support of the view that cyclin D has a pivotal
role in governing progression through G1 phase of the cell
cycle. The genes for cyclin D and its kinase partner Cdk4
are both transcribed in response to serum in cultured
mammalian cells [5]. Cyclin D–Cdk4 complexes efficiently
phosphorylate Rb in vitro and in vivo [6]. Hypophosphory-
lated Rb inhibits E2F in a simple stoichiometric fashion,
as well as by recruiting histone deacetylase activity to
E2F-responsive genes [1,7]. Phosphorylated Rb no longer
associates with or inhibits E2F activity, and free E2F has
been shown to activate the transcription of numerous
genes required for S-phase initiation and DNA replication.
Thus, a model consisting of a linear cascade of gene activi-
ties with cyclin D at the top, liberating E2F at the bottom
to irreversibly initiate cell division has developed over the
last few years.
This understanding of cyclin D function has, however,
evolved primarily from in vitro studies or work done with
cell cultures. Very little evidence exists from whole organ-
ism studies to support the proposed in vivo functions of
cyclin D. In knockout mice where individual cyclin D
genes have been disrupted, only modest defects are
observed [8,9]. These studies have been confounded by
the fact that mice have three different genes for cyclin D,
and two that encode potential Cdk partners for cyclin D.
Thus, a functional redundancy between the separate genes
has often been proposed to explain the mild phenotype in
the different knockout mice. Against this background it
seemed a good idea to turn to a different model organism,
in particular Drosophila. As mentioned above, the Drosophila
genome has only gene each for cyclin D and its kinase
partner. Furthermore, Drosophila cyclin D does not associ-
ate with other cyclin-dependent kinases, and cyclin
D–Cdk4 can phosphorylate Rb, indicating that the pro-
posed functions for cyclin D are conserved in Drosophila [3].
Slow growers
The two new papers [3,4] report the consequences of
mutations in the Drosophila gene for Cdk4, or of coordi-
nately overexpressing the genes for Cdk4 and cyclin D.
The most surprising revelation is that these genes are
dispensable for cell-cycle progression. Cells divide in the
absence of Cdk4 activity and overexpressing cyclin D–
Cdk4 does not accelerate G1 phase. The only apparent
phenotypic manifestation of manipulating cyclin D–Cdk4
activity is a disturbance in organ or organism growth. A
second twist to the tale is that, although cyclin D–Cdk4
can phosphorylate mouse Rb and does interact with the
Drosophila homologue of Rb, RBF, the effects of cyclin D
on growth appear to be independent of RBF.
Datar et al. [4] created transgenic flies in which the genes
for cyclin D and Cdk4 were overexpressed in distinct
regions or at specific times, and looked at the consequences
for growth and cell-cycle progression. It has previously been
demonstrated that increasing the rates of cell division in
specific compartments or clones of the developing wing
disc does not increase compartmental or clonal area because
cells compensate by becoming smaller [10]. Conversely,
decreasing rates of cell division does not decrease clonal
area, because cells within the clone become larger [10]. 
Datar et al. [4] found, however, that in the developing
Drosophila wing, clones of cells overexpressing cyclin D–
Cdk4 were larger than control clones, because they con-
tained a larger population of normal-size cells. This indi-
cates that overproduction of cyclin D–Cdk4 reduces cell
doubling time. Cells within the clones had the same cell-
cycle profile as control cells, indicating that cyclin D–
Cdk4 overexpression accelerates proliferation throughout
the entire cell cycle. As these cells did not have a reduced
size to compensate for their accelerated rate of division, it
follows that they must have also experienced an acceler-
ated growth rate. Excessive cellular growth was also seen
in post-mitotic cells of the differentiating eye on cyclin D–
Cdk4 overexpression, indicating that the growth observed
upon cyclin D–Cdk4 overexpression is not necessarily
linked to cell-cycle progression.
Equally telling is the approach taken by Meyer et al. [3],
who produced cdk4 mutant flies. Interestingly, the
homozygous mutants were viable, showing normal devel-
opment and eclosing at the expected time. Mutant adults
displayed moderate fertility defects and were able to
produce progeny. The cdk4 gene is therefore dispensible
for organism survival in general, and cell-cycle progression
in particular. But the mutant adults were smaller than
wild-type, with a reduction in body weight of about 20%.
The cdk4 mutant clones produced in the wing were also
smaller than their wild-type twin clones. Individual cells
in mutant flies or inside a mutant clone were of normal size.
Mutant cells did not show an increased rate of apoptosis.
The reduction in body or clonal size must then be caused
by a slower proliferation rate. The mutant cells did not,
however, have a prolonged G1 phase, as might have been
expected. Instead all phases of the cell cycle were equally
prolonged. As clones occupy a smaller area then their twin
wild-type clones, growth and proliferation are equally
affected in cdk4 mutant cells.
Rb or not Rb?
As in earlier work on mammalian systems, both groups
[3,4] observed numerous genetic and biochemical interac-
tions between cyclin D–Cdk4 and RBF. Stimulation of
growth by cyclin D appears, however, to be independent
of its ability to phosphorylate RBF [4]. For example, the
post-mitotic growth of the developing eye produced upon
overexpression of cyclin D–Cdk4 could not be suppressed
by coordinately overexpressing RBF. Furthermore, if
cyclin D–Cdk4 were to function solely by inactivating
RBF, one would expect RBF mutants to have the same
phenotype as cells overexpressing cyclin D–Cdk4, whereas
actually their phenotypes are quite different. Clones of
cells overexpressing cyclin D–Cdk4 grew and divided
faster than normal, but RBF mutant clones were no larger
than wild-type and their individual cells had a reduced size. 
In contrast to its mammalian homologues, Cdk4 does not
seem to be the principal RBF kinase in vivo [3]. Meyer
et al. [3] analyzed the phosphorylation status of mouse Rb
expressed in Drosophila embryos. Overproduction of
cyclin D–Cdk4 slightly enhanced Rb phosphorylation. A
more dramatic enhancement of Rb phosphorylation,
however, was seen upon overexpression of the gene for
cyclin E. Furthermore, overexpression of dacapo, the
Drosophila homologue of the cyclin E inhibitor p21, greatly
reduced Rb phosphorylation. These results suggest that
cyclin E–Cdk2 is the principal Rb/RBF kinase in Drosophila.
The new studies [3,4] suggest the existence of two distinct
cyclin D pathways in Drosophila. The first conforms to the
traditional function ascribed to cyclin D: cyclin D–Cdk4
phosphorylates RBF, allowing a cell to progress through
the cell cycle. RBF has been proposed to be a negative
regulator of both G1 and G2 in Drosophila [10]. This is
presumably why the entire cell cycle is slowed in cdk4
mutants, and why the rate of proliferation is accelerated in
clones of cells overproducing both Cdk4 and cyclin D.
Cyclin D is not, however, essential for cell-cycle progres-
sion, perhaps because of redundancy between cyclin D–
Cdk4 and cyclin E–Cdk2 in RBF inactivation. Cyclin D
also acts, apparently independently of RBF, in the cell-
autonomous control of cell growth. This is a new develop-
ment in our understanding of cyclin D and may explain
the hypotrophic phenotypes observed in some cyclin D
knockout mice [9]. It will be important to dissect the func-
tion of cyclin D in cell-growth control and determine to
what extent this process is tied in with cell division.
R666 Current Biology Vol 10 No 18
Figure 1


















To boldly grow where no fly has grown before…
For these further investigations it will be essential to have
mutants deficient in cyclin D. Such mutants are not yet
available, but the cdk4 mutant Drosophila phenotype gives
a good idea as to what to expect — sublethality with a
general drop in organism size. The availability of cyclin D
mutants should facilitate the next step forward — isolating
the downstream targets of cyclin D required for growth
and also for identifying the upstream ‘growth sensor’. 
In the budding yeast Saccharomyces cerevisiae, the G1 cyclin
Cln3 is proposed to perform such a function. Cln3 is
highly unstable and has several upstream open reading
frames in its mRNA, which are proposed to delay ribo-
some access to the start codon for translation of Cln3 [11].
During robust times of protein synthesis, as one would
expect to find in periods of growth, ribosome levels
increase, raising the likelihood of Cln3 translation. Even-
tually a critical threshold level of Cln3 is reached which
triggers cell-cycle initiation. This provides an elegant way
of coupling cell division to growth-friendly circumstances.
The mRNA for cyclin D has a complicated 5′ untranslated
region and has been suggested to act as a growth sensor.
This does not seem to be the case, however, as cdk4
mutants do not have a prolonged G1 phase and overpro-
duction of cyclin D–Cdk4 does not shorten G1. The
picture could also become more complicated as comple-
tion of the Drosophila genome sequence uncovered a
second Rb-like protein, RBF2. How this RBF2 fits into
the story remains to be determined.
There has been a large number of papers in the past few
years that significantly advance our understanding of how
growth may be regulated in a developing organism
(reviewed in [12]). The results from these papers indicate
the existence of two growth regulatory pathways. In the
first pathway, the insulin receptor responds to extracellu-
lar signals by activating intracellular molecules such as
phosphatidylinositol 3-kinase and S6 kinase [13–15]. One
consequence of this is increased synthesis of proteins
coded by a special class of mRNAs [16]. Most of these pro-
teins are involved in biosynthesis, indicating that insulin
signaling may upregulate general protein synthesis, an
obvious prerequisite for growth. It will be interesting to
see if there is some crosstalk between this signaling
pathway and cyclin D activity. 
A second growth regulatory pathway involves the activity
of at least two other proteins originally believed to be
involved only in cell-cycle progression, Ras and Myc
[17,18]. Drosophila Ras upregulates the activity of Myc,
which stimulates growth and also upregulates cyclin E
protein levels, enhancing progress through S phase. It is
attractive to think that cyclin D may belong in this hierar-
chy of proteins, especially as E2F is known to activate
transcription of the gene for cyclin E. If this is the case,
then cyclin D acts either upstream of, or parallel to, Ras
(see the model illustrated in Figure 1), as cyclin D
enhances progression through the cell cycle in general,
whereas Ras and Myc only enhance S phase entry.
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